Gaxos.ai: Early-Stage AI Innovator in Gaming & Health

Key Takeaways

• Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand.
• First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
• Feature-rich and partner-integrated – Gaxos Labs connects with leading AI providers like OpenAI, Suno, and ElevenLabs to deliver image, music, and voice generation for game content.
• Lean, high-upside model – With just three employees, growth potential hinges on partnerships, user adoption, and disciplined capital use.

About Gaxos.ai Gaxos.ai Inc. (NASDAQ: GXAI), based in Roseland, NJ, pivoted in January 2024 from its former identity as The NFT Gaming Company to focus on artificial intelligence, one of the fastest-growing sectors in tech.

The company operates in two major markets:

• Gaming – Its flagship Gaxos Labs platform provides Unity-compatible AI tools that let studios instantly generate characters, skins, and environments, enabling faster game development and new monetization models like player-created in-game items.
• Health – Through RNK Health, Gaxos delivers AI-driven wellness solutions, including personalized longevity programs, metabolic health tracking, and GLP-1-based weight management.

Other initiatives include UnGPT.ai, an AI text rewriting platform.

Catalysts

Health Revenue Marks First Step Toward Scaling Gaxos grew revenue from $4k in 2024 to ~$24k in H1 2025, driven by RNK Health pilots. Early results suggest strong interest in AI-powered personalized coaching, telehealth services, and data-driven treatment recommendations. The $7 trillion global wellness market offers a massive runway for growth.

AI Gaming Tailwinds Roughly 40% of developers now use AI tools, and Unity/Roblox are expanding AI capabilities. With direct Unity integration, Gaxos Labs allows indie and mid-tier studios to deploy AI without building internal infrastructure, saving time and enabling new in-game revenue models.

Two Booming Markets = Double Optionality Gaming offers B2B SaaS licensing and revenue-sharing opportunities, while health offers both subscription-based consumer services and potential B2B partnerships (corporate wellness, specialty clinics).

All-in-One AI Stack By bundling OpenAI’s image generation, Suno’s music, and ElevenLabs’ voice into one platform, Gaxos removes barriers for studios without in-house AI teams. Over time, proprietary models or exclusive content partnerships could further lock in customers.

Assumptions & Valuation

• Short-term – Revenue could reach $0.5–1M by YE 2025 as RNK Health expands and gaming pilots transition to paying contracts.
• Long-term – By 2030, ~$10M in revenue is possible from a mix of gaming SaaS, revenue-share deals, and health subscriptions.
• Margins – Gross margins could exceed 70%, with net margins of ~20% at scale.
• Valuation – Applying a 20× P/E multiple to $2M in 2030 net income implies ~$40M in value. If we assume shares outstanding grow at 10% per year, that results in shares outstanding figure of 11.42m by 2030. Then, $40m / 11.42m shares is $3.50 per share by 2030.
• Fair value: Discounting that back to 2025 at 8.95% per year, that gives us a fair value of around $2.21 per share — more than double the current ~$1.10 share price.

Risks

• Early-stage revenue base – With only modest sales to date, Gaxos must prove its products can scale. If it succeeds, the growth potential from this low base is significant.
• Small team – Just 3 employees means limited capacity, but also the ability to remain lean and agile while leveraging contractors and partners for scale.
• Recent pivot to AI – Shifting from NFTs to AI could be seen as opportunistic; however, it aligns the company with one of the fastest-growing sectors in tech.
• Competitive landscape – Larger, well-funded players in gaming and health could outpace Gaxos, but the company’s niche focus may allow it to carve out defensible segments.
• Future funding needs – Additional financing will likely be required before profitability, which could dilute shareholders but also provide the capital needed for expansion.
• Microcap volatility – As a ~$8M market cap stock, shares may be highly volatile; this creates risk, but also potential upside if catalysts play out positively.

Conclusion Gaxos.ai is a small, agile AI company targeting two of the fastest-growing markets in tech. Early health revenue is a promising signal, and gaming tools are positioned to benefit from the industry’s rapid AI adoption.

If management executes on both verticals, $10M in annual revenue by 2030 is achievable — potentially justifying a valuation multiple times higher than today. For investors comfortable with early-stage volatility, GXAI offers an asymmetric bet on AI’s future in gaming and health.